clotrimazole has been researched along with eberconazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Espasa, M; Jimenez, T; Lagunas, C; López-Jodra, O; Mendez, R; Morera, Y; Torres-Rodríguez, JM | 1 |
| del Palacio, A; Font, E; Garau, M; Ortiz, FJ; Pazos, C; Pérez, A | 1 |
| Lee, A; Saeed, SR; Tysome, JR | 1 |
1 review(s) available for clotrimazole and eberconazole
| Article | Year |
|---|---|
Topical azole treatments for otomycosis.
Topics: Administration, Topical; Adult; Antifungal Agents; Bias; Child; Clotrimazole; Cycloheptanes; Fluconazole; Humans; Imidazoles; Miconazole; Otomycosis; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
1 trial(s) available for clotrimazole and eberconazole
| Article | Year |
|---|---|
A double-blind randomized comparative trial: eberconazole 1% cream versus clotrimazole 1% cream twice daily in Candida and dermatophyte skin infections.
Topics: Administration, Topical; Antifungal Agents; Arthrodermataceae; Candida; Candidiasis; Clotrimazole; Cycloheptanes; Dermatomycoses; Double-Blind Method; Epidermophyton; Humans; Imidazoles; Treatment Outcome; Trichophyton | 2001 |
1 other study(ies) available for clotrimazole and eberconazole
| Article | Year |
|---|---|
In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole.
Topics: Antifungal Agents; Candida; Clotrimazole; Cryptococcus; Cycloheptanes; Imidazoles; Ketoconazole; Microbial Sensitivity Tests | 1999 |